Medicinal aerosol formulations
OwnerPhillip A Jinks, Lesley McKenzie +1inventors
InventorsPhillip A Jinks, Lesley McKenzie, James T. Lister
Life of this patent
Estimating the term…
Abstract
Use of particulate bulking agents having an extremely small mass median diameter of less than one micron, preferably less than 300 nm, in pharmaceutical aerosol formulations comprising a suspension of drug particles in a propellant. Examples of bulking agents include ascorbic acid, saccharides, polysaccharides, amino acids, organic and inorganic salts, urea, and propyliodone.
Claims43
The use of a particulate bulking agent having a mass median diameter of less than one micron in pharmaceutical aerosol formulations comprising a suspension of drug particles in a propellant.
The use as claimed in any preceding claim in which the bulking agent is lactose.
The use as claimed in any preceding claim in which the bulking agent has a mass median diameter of not more than 300 nm.
The use as claimed in any preceding claim in which the bulking agent has a mass median diameter of not more than 250 nm.
The use as claimed in any preceding claim in which the weight ratio of drug bulking agent is in the range 1:0.1 to 1:100.
The use as claimed in any preceding claim in which the drug has a mass median diameter equal to or greater than 1 micron.
The use as claimed in any preceding claim in which the bulking agent is added to the formulation in the form of a slurry or thick paste.
The use as claimed in any preceding claim in which the drug is selected from Formoterol, Salmeterol, Fluticasone Propionate, Procaterol and Ipratropium and salts thereof.
The use as claimed in any preceding claim in which the propellant is a hydrofluoroalkane.
A pharmaceutical aerosol formulation comprising particles of drug dispersed in a propellant and a bulking agent having a mass median diameter of less than one micron.
A process for the preparation of an aerosol formulation comprising a suspension of particles in propellant which process comprises forming a slurry of bulking agent with a component of the aerosol formulation, subjecting the slurry to high pressure homogenization to reduce the particle size of the bulking agent, and thereafter mixing the resulting slurry with other components of the aerosol formulation.
Dependencies are inferred from the claim text.